Keyphrases
T Cells
81%
Neuroblastoma
70%
MHC Class II
57%
Organoids
43%
Natural Killer Cells
42%
Cord Blood
41%
T Cell Receptor
37%
CD8+ T Cells
32%
High-risk Neuroblastoma
32%
Engineered T Cells
29%
Dendritic Cells
27%
MHC Class I
27%
Cancer Immunotherapy
27%
In Cancer
27%
Cell Lineage
27%
Cellular Immunotherapy
21%
Immune Monitoring
20%
Immune Cells
20%
Solid Tumors
20%
Tumor Cells
18%
Flow Cytometer
18%
Tumor
17%
Immunogenicity
17%
Mode of Action
17%
Relapsed or Refractory Acute Myeloid Leukemia
17%
Cell-based
16%
Killing Assay
16%
Drug Library Screening
16%
High-throughput Flow Cytometry
16%
Adherent Cells
16%
Immune Response
16%
Cancer Therapy
15%
Gene Editing
15%
Adoptive Cell Therapy
15%
Lentiviral Transduction
15%
Integrative Analysis
13%
TIGIT
13%
MR1T
13%
Nectin-2
13%
Clustered Regularly Interspaced Short Palindromic repeats/Cas9
13%
Single-cell RNA Sequencing (scRNA-seq)
13%
Checkpoint Molecules
13%
Microplate Format
13%
Staining Method
13%
384-well
13%
Touchless
13%
High-throughput System
13%
Regulatory Immune Response
13%
Transduction Methods
13%
Anti-tumor Response
13%
Immunology and Microbiology
T Cell
100%
Immunotherapy
70%
Organoid
56%
Natural Killer Cell
37%
T Cell Receptor
32%
Major Histocompatibility Complex
30%
Cell Lineage
27%
Cancer Immunotherapy
27%
Immunology
21%
Immunity
21%
Tumor Cell
20%
Immunocompetent Cell
20%
Immunogenicity
18%
Myeloid
18%
Coculture
17%
Cytotoxic T-Cell
16%
Cell Function
16%
Immune Response
15%
Adherent Cell
15%
Cytotoxicity
15%
Hematopoietic Cell
15%
RNA Sequence
13%
MHC Class I
13%
Lineages
13%
Downregulation
13%
Staining
13%
Dendritic Cell
13%
CRISPR/Cas9
13%
High Throughput Screening
9%
Programmed Death-Ligand 1
9%
Gene Expression Assay
7%
Cytokine
7%
Lentivirus Vector
6%
Intravenous Immunoglobulin
6%
Cell Line
6%
Neuroblastoma Cell
5%
Neuroblastoma Cell Line
5%
Dinutuximab
5%
Dynamics
5%
Survival Rate
5%
interferon
5%
Medicine and Dentistry
T Cell
69%
Ganglioneuroblastoma
44%
Immunotherapy
44%
Organoid
34%
T Lymphocyte Receptor
33%
Neoplasm
27%
Clustered Regularly Interspaced Short Palindromic Repeat
27%
Dendritic Cell
27%
Cord Blood
27%
Natural Killer Cell
18%
Pediatrics
18%
Major Histocompatibility Complex
17%
Cytotoxic T-Cell
16%
RNA Sequence
16%
Hematopoietic Cell
16%
Adherent Cell
15%
Flow Cytometry
15%
CRISPR Associated Protein
13%
Pediatric Cancer
13%
Tumor Cell
13%
Cas9
13%
Cell Lineage
13%
Immunogenicity
13%
Acute Myeloid Leukemia
13%
Hematologic Malignancy
13%
Cytotoxicity
13%
Malignant Neoplasm
11%
Cell Therapy
11%
In Vitro
10%
T Cell Receptor
9%
Histone Deacetylase Inhibitor
8%
Wilms' Tumor
8%
High Throughput Screening
7%
Human Leukocyte Antigen
6%
Leukemia
6%
Survival Rate
6%
Dinutuximab
5%
Programmed Death-Ligand 1
5%
Cytometry
5%
Chemotherapy
5%
Neuroblastoma Cell
5%
Neuroblastoma Cell Line
5%
